MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) CEO To Present at Needham Healthcare Conference
4/23/2013 7:43:55 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL)'s Mitochondrial Inhibitor Drug Candidate ME-344 Delays Tumor Growth in Recurrent Ovarian Cancer Model
4/11/2013 9:29:21 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces $15.2 Million Registered Offering of Common Stock
4/5/2013 7:29:24 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) to Host Annual Meeting of Stockholders
3/21/2013 9:37:47 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) CEO to Present at ROTH Conference
3/12/2013 7:32:43 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) to Present at Cowen and Company Health Care Conference
2/27/2013 7:24:52 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Adds Cancer Drug Development Veteran Tom Reynolds to Board of Directors
2/11/2013 9:35:10 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces Retirement of Chairman Bryan Williams From Board of Directors and Appointment of Christine White as Lead Director
1/30/2013 7:13:12 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces Closing of $27.5 Million Private Placement
12/19/2012 7:05:06 AM
More...
|
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL)'s Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
11/19/2012 10:31:16 AM
More...
|
|